In a breast cancer cohort, Lou et al.21 demonstrated an elevated expression pattern of PTTG3P and discovered that PTTG3P expression correlated negatively with estrogen receptor (ER) and progesterone receptor (PR) status. Here, ESR1 is linked to breast cancer.